NCT05182385
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05182385
Title Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Goethe University
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Universitätsklinikum Tübingen Tübingen Baden-Wurttemberg 72076 Germany Details
Universitätsklinikum Ulm Ulm Baden-Wurttemberg 89081 Germany Details
University Hospital of Frankfurt (Main) Frankfurt am Main Hesse 60590 Germany Details
Universitätsklinikum Dresden Dresden Saxony 01307 Germany Details
Charité - Campus Benjamin Franklin Berlin 12203 Germany Details
Universitätsklinikum Köln Cologne 50937 Germany Details
University Hospital Düsseldorf Düsseldorf 40225 Germany Details
Universität Erlangen Erlangen Germany Details
Universitätsklinikum Essen Essen Germany Details
Universitätsklinikum Hamburg-Eppendorf Hamburg 20246 Germany Details
Universitätsklinikum Heidelberg Heidelberg 69120 Germany Details
UKSH-Kiel Kiel Germany Details
Universitätsklinik Leipzig Leipzig Germany Details
Klinikum Mannheim Mannheim Germany Details
Klinikum Rechts der Isar der TU München München 81675 Germany Details
Klinikum Oldenburg Oldenburg 26133 Germany Details
Robert - Bosch - Krankenhaus Stuttgart Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field